A new dawn for Diabetic kidney disease: interleukin receptor antagonists

A new dawn for Diabetic kidney disease: interleukin receptor antagonists

Saved in:

Bibliographic Details
Main Authors:	LuYao Shi, Tao Wei, Zhang Liang, ChangYan Li, Tao Liu, WenXing Fan
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	Journal of Translational Medicine
Online Access:	https://doi.org/10.1186/s12967-024-05798-0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Serum interleukin-6, interleukin-8, and interleukin-1 receptor antagonist levels in South Indian fibromyalgia patients and its correlation with disease severity
by: Sandeep Surendran, et al.
Published: (2021-01-01)

Investigating the inflammatory mechanism of notoginsenoside R1 in Diabetic nephropathy via ITGB8 based on network pharmacology and experimental validation
by: ChangYan Li, et al.
Published: (2024-12-01)

Deficiency of interleukin-1 receptor antagonist: An updated review of the pathogenesis, clinical characteristics, and treatments
by: Spencer Fang, et al.
Published: (2024-12-01)

Impact of an Interleukin-1 Receptor Antagonist and Erythropoietin on Experimental Myocardial Ischemia/Reperfusion Injury
by: Christina Grothusen, et al.
Published: (2012-01-01)

Finerenone: a breakthrough mineralocorticoid receptor antagonist for heart failure, diabetes and chronic kidney disease
by: Akshyaya Pradhan, et al.
Published: (2024-12-01)

DNA Methyltransferase 3B Gene Promoter and Interleukin-1 Receptor Antagonist Polymorphisms in Childhood Immune Thrombocytopenia
by: Margarita Pesmatzoglou, et al.
Published: (2012-01-01)

The Dawn of European Civilization /
by: Childe, V. Gordon (Vere Gordon), 1892-1957
Published: (1957)

Interview with Dawn Raffel
by: Monica Manolescu-Oancea
Published: (2011-04-01)

The Dawn of Statistical ASR and MT
by: Frederick Jelinek
Published: (2021-03-01)

George Gissing, Workers in the Dawn
by: Christine Huguet
Published: (2010-12-01)

Gene therapy in preeclampsia: the dawn of a new era
by: Fengxuan Sun, et al.
Published: (2024-12-01)

Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review
by: Kisho Miyasako, et al.
Published: (2024-12-01)

Deficiency of Interleukin-1 Receptor Antagonist: A Case with Late Onset Severe Inflammatory Arthritis, Nail Psoriasis with Onychomycosis and Well Responsive to Adalimumab Therapy
by: Necil Kutukculer, et al.
Published: (2019-01-01)

Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
by: Vincenzo Montesarchio, et al.
Published: (2020-10-01)

Dawn of an era of effective treatments for MAFLD
by: Cameron Gofton, et al.
Published: (2024-12-01)

Dawn Raffel–A Family Portrait
by: Monica Manolescu-Oancea
Published: (2011-04-01)

Correction: Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
Published: (2020-10-01)

Russia – Ukraine War: Dawn of a New World Order?
by: Sobia Khursheed
Published: (2024-12-01)

Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients
by: Hölsken S, et al.
Published: (2025-01-01)

The effects of the urotensin-II receptor antagonist palosuran treatment on the corpora cavernosa of streptozotocin-induced diabetic rats
by: Murat Olukman, et al.
Published: (2025-01-01)

The Oxytocin-Oxytocin Receptor System and Its Antagonists as Tocolytic Agents
by: Nikolaos Vrachnis, et al.
Published: (2011-01-01)

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
by: Gregory R. Tintinger, et al.
Published: (2010-01-01)

An antagonistic role of clock genes and lima1 in kidney regeneration
by: Xian He, et al.
Published: (2025-01-01)

Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus
by: Ranadheer R. Dande, et al.
Published: (2017-01-01)

Big pictures after Dawn: ‘ontology’ for historians and utopians
by: John Tresch, et al.
Published: (2024-01-01)

Effectiveness and safety of mineralocorticoid receptor antagonists in heart failure patients with and without diabetes: a systematic review and meta-analysis
by: Arga Setyo Adji, et al.
Published: (2024-11-01)

Antibiotic Resistance in Canada at the Dawn of the New Millennium -- A Model for the Developed World?
by: John M Conly, et al.
Published: (2000-01-01)

Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors
by: Alejandro Diaz-Barreiro, et al.
Published: (2025-01-01)

Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
by: Andrew H. Han, et al.
Published: (2023-01-01)

Histamine H2 Receptor Antagonists in the Treatment and Prevention of Heart Failure
by: Wang D, et al.
Published: (2024-12-01)

Neurokinin-1 Receptor Antagonist Treatment in Polymicrobial Sepsis: Molecular Insights
by: Akhil Hegde, et al.
Published: (2010-01-01)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
by: T. Robak, et al.
Published: (1998-01-01)

The inhibitory effect of type V transforming growth factor-β receptor antagonist on the proliferation of keloid fibroblasts by suppressing insulin-like growth factor-binding protein 3-interleukin-6 signaling
by: Boya Zhou, et al.
Published: (2024-11-01)

Serum levels of interleukin-6 are not dependent on the kidney function
by: L. Nässberger
Published: (1992-01-01)

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease
by: Yu Yang, et al.
Published: (2017-01-01)

CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?
by: Carlos Rangel-Peláez, et al.
Published: (2024-12-01)

The Decline of Economic and Political Freedom After Covid‐19: A New Authoritarian Dawn?
by: Christopher A. Hartwell
Published: (2024-12-01)

Mitochondrial quality control: the real dawn of intervertebral disc degeneration?
by: Ba Qiu, et al.
Published: (2024-12-01)

The Night’s Journey and the Return of Christ, the Dawn of Postmodern Fiction in Iran
by: فاطمه جعفری کمانگر, et al.
Published: (2014-06-01)

Characteristics in Molecular Vibrational Frequency Patterns between Agonists and Antagonists of Histamine Receptors
by: S. June Oh
Published: (2012-06-01)